SCHEMBL16301492

SCHEMBL16301492

CC(=O)NC1[C@H](O[C@@H]2C(CO)O[C@@H](C)C(NC(C)=O)[C@H]2O)OC(CO)[C@@H](O[C@@H]2OC(CO)[C@@H](O)C(O[C@H]3O[C@H](CO)[C@@H](O)C(O)C3O[C@@H]3OC(CO)[C@@H](O[C@@H]4OC(CO)[C@H](O)C(O[C@]5(C(=O)O)C[C@@H](O)[C@@H](NC(C)=O)C([C@H](O)[C@H](O)CO)O5)[C@@H]4O)C(O)[C@@H]3NC(C)=O)[C@H]2O)[C@@H]1O

nearest known ligand 0.66

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.65
▸ MAG P20916 8/20 0.64
▸ SELP P16109 2/20 0.61
▸ SELL P14151 1/20 0.61
▸ SELE P16581 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15849917 1.00 SIGLEC7 (0.65) SIGLEC7MAGSELPSELLSELE
SCHEMBL13541590 0.97 SIGLEC7 (0.67) SIGLEC7MAGSELPSELLSELE
SCHEMBL13663172 0.95 SIGLEC7 (0.68) SIGLEC7MAGSELPSELLSELE
SCHEMBL21064181 0.95 SIGLEC7 (0.68) SIGLEC7MAGSELPSELLSELE
SCHEMBL13541582 0.95 SIGLEC7 (0.68) SIGLEC7MAGSELPSELLSELE
SCHEMBL15849921 0.94 SIGLEC7 (0.65) SIGLEC7MAGSELPSELLSELE
SCHEMBL31701592 0.92 SIGLEC7 (0.69) SIGLEC7MAGSELPSELLSELE
SCHEMBL31700988 0.92 SIGLEC7 (0.69) SIGLEC7MAGSELPSELLSELE
SCHEMBL30862157 0.92 SIGLEC7 (0.69) SIGLEC7MAGSELPSELLSELE
SCHEMBL31700975 0.92 SIGLEC7 (0.69) SIGLEC7MAGSELPSELLSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110313136-A1 IgG-Fc FRAGMENT AND PROCESS FOR PRODUCING THE SAME OTSUKA CHEMICAL CO., LTD. (JP) 2011-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110313136-A1 IgG-Fc FRAGMENT AND PROCESS FOR PRODUCING THE SAME FCGR1A, FCGR2A, FCGR3B SIGLEC7 11/4885MAG 332/4885SELP 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback